nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—PGK1—connective tissue—chronic obstructive pulmonary disease	0.0165	0.0813	CbGeAlD
Lamivudine—NT5C—respiratory system—chronic obstructive pulmonary disease	0.0158	0.078	CbGeAlD
Lamivudine—PCYT1A—respiratory system—chronic obstructive pulmonary disease	0.0148	0.0732	CbGeAlD
Lamivudine—PCYT1A—connective tissue—chronic obstructive pulmonary disease	0.0131	0.0644	CbGeAlD
Lamivudine—NME1—respiratory system—chronic obstructive pulmonary disease	0.00992	0.0489	CbGeAlD
Lamivudine—CMPK1—respiratory system—chronic obstructive pulmonary disease	0.00956	0.0472	CbGeAlD
Lamivudine—NME2—respiratory system—chronic obstructive pulmonary disease	0.00934	0.0461	CbGeAlD
Lamivudine—NME1—connective tissue—chronic obstructive pulmonary disease	0.00873	0.0431	CbGeAlD
Lamivudine—CMPK1—connective tissue—chronic obstructive pulmonary disease	0.00841	0.0415	CbGeAlD
Lamivudine—NT5C—lung—chronic obstructive pulmonary disease	0.00839	0.0414	CbGeAlD
Lamivudine—PCYT1A—lung—chronic obstructive pulmonary disease	0.00787	0.0389	CbGeAlD
Lamivudine—CMPK1—bronchus—chronic obstructive pulmonary disease	0.00786	0.0388	CbGeAlD
Lamivudine—CMPK1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00769	0.038	CbGeAlD
Lamivudine—NME2—bronchus—chronic obstructive pulmonary disease	0.00769	0.0379	CbGeAlD
Lamivudine—NME1—lung—chronic obstructive pulmonary disease	0.00526	0.026	CbGeAlD
Lamivudine—CMPK1—lung—chronic obstructive pulmonary disease	0.00507	0.025	CbGeAlD
Lamivudine—NME2—lung—chronic obstructive pulmonary disease	0.00496	0.0245	CbGeAlD
Lamivudine—ABCC3—respiratory system—chronic obstructive pulmonary disease	0.00456	0.0225	CbGeAlD
Lamivudine—DCK—bronchus—chronic obstructive pulmonary disease	0.00392	0.0193	CbGeAlD
Lamivudine—DCK—trachea—chronic obstructive pulmonary disease	0.00352	0.0174	CbGeAlD
Lamivudine—SLC22A3—connective tissue—chronic obstructive pulmonary disease	0.00341	0.0168	CbGeAlD
Lamivudine—SLC22A3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00312	0.0154	CbGeAlD
Lamivudine—ABCC4—bronchus—chronic obstructive pulmonary disease	0.00309	0.0153	CbGeAlD
Lamivudine—ABCC1—bronchus—chronic obstructive pulmonary disease	0.00264	0.013	CbGeAlD
Lamivudine—DCK—lung—chronic obstructive pulmonary disease	0.00253	0.0125	CbGeAlD
Lamivudine—ABCC3—lung—chronic obstructive pulmonary disease	0.00242	0.0119	CbGeAlD
Lamivudine—ABCC1—trachea—chronic obstructive pulmonary disease	0.00237	0.0117	CbGeAlD
Lamivudine—SLC22A3—lung—chronic obstructive pulmonary disease	0.00206	0.0102	CbGeAlD
Lamivudine—ABCC4—lung—chronic obstructive pulmonary disease	0.002	0.00985	CbGeAlD
Lamivudine—ABCC1—lung—chronic obstructive pulmonary disease	0.0017	0.0084	CbGeAlD
Lamivudine—ABCG2—lung—chronic obstructive pulmonary disease	0.00141	0.00696	CbGeAlD
Lamivudine—DCK—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00134	0.257	CbGdCrCtD
Lamivudine—DCK—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00131	0.251	CbGdCrCtD
Lamivudine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00131	0.00646	CbGeAlD
Lamivudine—DCK—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00131	0.249	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.243	CbGdCrCtD
Lamivudine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000967	0.00477	CbGeAlD
Lamivudine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000812	0.0013	CcSEcCtD
Lamivudine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000808	0.0013	CcSEcCtD
Lamivudine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000808	0.0013	CcSEcCtD
Lamivudine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000801	0.00129	CcSEcCtD
Lamivudine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000801	0.00129	CcSEcCtD
Lamivudine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.0008	0.00128	CcSEcCtD
Lamivudine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.0008	0.00128	CcSEcCtD
Lamivudine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000798	0.00128	CcSEcCtD
Lamivudine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000797	0.00128	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000796	0.00128	CcSEcCtD
Lamivudine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000795	0.00127	CcSEcCtD
Lamivudine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000792	0.00127	CcSEcCtD
Lamivudine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000784	0.00126	CcSEcCtD
Lamivudine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000784	0.00126	CcSEcCtD
Lamivudine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000784	0.00126	CcSEcCtD
Lamivudine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000784	0.00126	CcSEcCtD
Lamivudine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000779	0.00125	CcSEcCtD
Lamivudine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000779	0.00125	CcSEcCtD
Lamivudine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000772	0.00124	CcSEcCtD
Lamivudine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000772	0.00124	CcSEcCtD
Lamivudine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000772	0.00124	CcSEcCtD
Lamivudine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000772	0.00124	CcSEcCtD
Lamivudine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00077	0.00124	CcSEcCtD
Lamivudine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000769	0.00123	CcSEcCtD
Lamivudine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000769	0.00123	CcSEcCtD
Lamivudine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000768	0.00123	CcSEcCtD
Lamivudine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000768	0.00123	CcSEcCtD
Lamivudine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000768	0.00123	CcSEcCtD
Lamivudine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000763	0.00122	CcSEcCtD
Lamivudine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000763	0.00122	CcSEcCtD
Lamivudine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000762	0.00122	CcSEcCtD
Lamivudine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000762	0.00122	CcSEcCtD
Lamivudine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000762	0.00122	CcSEcCtD
Lamivudine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000759	0.00122	CcSEcCtD
Lamivudine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.00121	CcSEcCtD
Lamivudine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000753	0.00121	CcSEcCtD
Lamivudine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000752	0.00121	CcSEcCtD
Lamivudine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000752	0.00121	CcSEcCtD
Lamivudine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000751	0.0012	CcSEcCtD
Lamivudine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000746	0.0012	CcSEcCtD
Lamivudine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00074	0.00119	CcSEcCtD
Lamivudine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00074	0.00119	CcSEcCtD
Lamivudine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000736	0.00118	CcSEcCtD
Lamivudine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000733	0.00118	CcSEcCtD
Lamivudine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.00118	CcSEcCtD
Lamivudine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000732	0.00117	CcSEcCtD
Lamivudine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000729	0.00117	CcSEcCtD
Lamivudine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000728	0.00117	CcSEcCtD
Lamivudine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000727	0.00117	CcSEcCtD
Lamivudine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000726	0.00117	CcSEcCtD
Lamivudine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000719	0.00115	CcSEcCtD
Lamivudine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000716	0.00115	CcSEcCtD
Lamivudine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000716	0.00115	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000714	0.00115	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000714	0.00115	CcSEcCtD
Lamivudine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000709	0.00114	CcSEcCtD
Lamivudine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000709	0.00114	CcSEcCtD
Lamivudine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000706	0.00113	CcSEcCtD
Lamivudine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000705	0.00113	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.0007	0.00112	CcSEcCtD
Lamivudine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000699	0.00112	CcSEcCtD
Lamivudine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000699	0.00112	CcSEcCtD
Lamivudine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000697	0.00112	CcSEcCtD
Lamivudine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000697	0.00112	CcSEcCtD
Lamivudine—ABCB1—lung—chronic obstructive pulmonary disease	0.000695	0.00343	CbGeAlD
Lamivudine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000695	0.00111	CcSEcCtD
Lamivudine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00111	CcSEcCtD
Lamivudine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00111	CcSEcCtD
Lamivudine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00111	CcSEcCtD
Lamivudine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00069	0.00111	CcSEcCtD
Lamivudine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000687	0.0011	CcSEcCtD
Lamivudine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000683	0.0011	CcSEcCtD
Lamivudine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000683	0.0011	CcSEcCtD
Lamivudine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000681	0.00109	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000677	0.00109	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000677	0.00109	CcSEcCtD
Lamivudine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000676	0.00108	CcSEcCtD
Lamivudine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000676	0.00108	CcSEcCtD
Lamivudine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000676	0.00108	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00108	CcSEcCtD
Lamivudine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000671	0.00108	CcSEcCtD
Lamivudine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000671	0.00108	CcSEcCtD
Lamivudine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000671	0.00108	CcSEcCtD
Lamivudine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000671	0.00108	CcSEcCtD
Lamivudine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00067	0.00107	CcSEcCtD
Lamivudine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.00107	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000663	0.00106	CcSEcCtD
Lamivudine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000662	0.00106	CcSEcCtD
Lamivudine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00066	0.00106	CcSEcCtD
Lamivudine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000658	0.00106	CcSEcCtD
Lamivudine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000657	0.00105	CcSEcCtD
Lamivudine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000655	0.00105	CcSEcCtD
Lamivudine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000653	0.00105	CcSEcCtD
Lamivudine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000652	0.00105	CcSEcCtD
Lamivudine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00065	0.00104	CcSEcCtD
Lamivudine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000649	0.00104	CcSEcCtD
Lamivudine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000646	0.00104	CcSEcCtD
Lamivudine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000646	0.00104	CcSEcCtD
Lamivudine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000645	0.00104	CcSEcCtD
Lamivudine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000644	0.00103	CcSEcCtD
Lamivudine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000643	0.00103	CcSEcCtD
Lamivudine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000641	0.00103	CcSEcCtD
Lamivudine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000641	0.00103	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000639	0.00103	CcSEcCtD
Lamivudine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00102	CcSEcCtD
Lamivudine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000633	0.00102	CcSEcCtD
Lamivudine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000633	0.00102	CcSEcCtD
Lamivudine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000628	0.00101	CcSEcCtD
Lamivudine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000623	0.001	CcSEcCtD
Lamivudine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000623	0.001	CcSEcCtD
Lamivudine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.000995	CcSEcCtD
Lamivudine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00062	0.000995	CcSEcCtD
Lamivudine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00062	0.000995	CcSEcCtD
Lamivudine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.000995	CcSEcCtD
Lamivudine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000618	0.000992	CcSEcCtD
Lamivudine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000618	0.000991	CcSEcCtD
Lamivudine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000613	0.000983	CcSEcCtD
Lamivudine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000612	0.000982	CcSEcCtD
Lamivudine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000612	0.000982	CcSEcCtD
Lamivudine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00061	0.000979	CcSEcCtD
Lamivudine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00061	0.000979	CcSEcCtD
Lamivudine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000609	0.000977	CcSEcCtD
Lamivudine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000607	0.000974	CcSEcCtD
Lamivudine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000607	0.000974	CcSEcCtD
Lamivudine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000605	0.000972	CcSEcCtD
Lamivudine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000595	0.000954	CcSEcCtD
Lamivudine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000588	0.000944	CcSEcCtD
Lamivudine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000585	0.000939	CcSEcCtD
Lamivudine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000585	0.000939	CcSEcCtD
Lamivudine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000578	0.000927	CcSEcCtD
Lamivudine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000578	0.000927	CcSEcCtD
Lamivudine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000577	0.000926	CcSEcCtD
Lamivudine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000566	0.000908	CcSEcCtD
Lamivudine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000563	0.000903	CcSEcCtD
Lamivudine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000563	0.000903	CcSEcCtD
Lamivudine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000555	0.00089	CcSEcCtD
Lamivudine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000555	0.00089	CcSEcCtD
Lamivudine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000554	0.000889	CcSEcCtD
Lamivudine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000554	0.000889	CcSEcCtD
Lamivudine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000551	0.000884	CcSEcCtD
Lamivudine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000546	0.000877	CcSEcCtD
Lamivudine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000546	0.000875	CcSEcCtD
Lamivudine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000543	0.000872	CcSEcCtD
Lamivudine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000537	0.000861	CcSEcCtD
Lamivudine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000537	0.000861	CcSEcCtD
Lamivudine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000532	0.000854	CcSEcCtD
Lamivudine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000531	0.000852	CcSEcCtD
Lamivudine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000529	0.000848	CcSEcCtD
Lamivudine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000526	0.000843	CcSEcCtD
Lamivudine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000524	0.000841	CcSEcCtD
Lamivudine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00052	0.000835	CcSEcCtD
Lamivudine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000519	0.000832	CcSEcCtD
Lamivudine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000519	0.000832	CcSEcCtD
Lamivudine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000508	0.000815	CcSEcCtD
Lamivudine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000507	0.000814	CcSEcCtD
Lamivudine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000507	0.000813	CcSEcCtD
Lamivudine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000499	0.0008	CcSEcCtD
Lamivudine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000499	0.0008	CcSEcCtD
Lamivudine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000494	0.000793	CcSEcCtD
Lamivudine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000494	0.000793	CcSEcCtD
Lamivudine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000494	0.000793	CcSEcCtD
Lamivudine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000494	0.000793	CcSEcCtD
Lamivudine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000491	0.000788	CcSEcCtD
Lamivudine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000491	0.000788	CcSEcCtD
Lamivudine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.000786	CcSEcCtD
Lamivudine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00049	0.000786	CcSEcCtD
Lamivudine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000488	0.000784	CcSEcCtD
Lamivudine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000484	0.000777	CcSEcCtD
Lamivudine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000484	0.000776	CcSEcCtD
Lamivudine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000483	0.000775	CcSEcCtD
Lamivudine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000482	0.000774	CcSEcCtD
Lamivudine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000481	0.000772	CcSEcCtD
Lamivudine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000475	0.000763	CcSEcCtD
Lamivudine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000474	0.000761	CcSEcCtD
Lamivudine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.000755	CcSEcCtD
Lamivudine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000469	0.000753	CcSEcCtD
Lamivudine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000468	0.00075	CcSEcCtD
Lamivudine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000467	0.000749	CcSEcCtD
Lamivudine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000467	0.000749	CcSEcCtD
Lamivudine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000466	0.000748	CcSEcCtD
Lamivudine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000466	0.000747	CcSEcCtD
Lamivudine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000466	0.000747	CcSEcCtD
Lamivudine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000464	0.000744	CcSEcCtD
Lamivudine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000457	0.000734	CcSEcCtD
Lamivudine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000456	0.000732	CcSEcCtD
Lamivudine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000451	0.000723	CcSEcCtD
Lamivudine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00044	0.000706	CcSEcCtD
Lamivudine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000438	0.000702	CcSEcCtD
Lamivudine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000427	0.000685	CcSEcCtD
Lamivudine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000425	0.000681	CcSEcCtD
Lamivudine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000425	0.000681	CcSEcCtD
Lamivudine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000418	0.00067	CcSEcCtD
Lamivudine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000411	0.000659	CcSEcCtD
Lamivudine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000392	0.00063	CcSEcCtD
Lamivudine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000384	0.000616	CcSEcCtD
Lamivudine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000384	0.000616	CcSEcCtD
Lamivudine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000381	0.000612	CcSEcCtD
Lamivudine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000378	0.000607	CcSEcCtD
Lamivudine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000378	0.000607	CcSEcCtD
Lamivudine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000363	0.000583	CcSEcCtD
Lamivudine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000351	0.000563	CcSEcCtD
Lamivudine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00035	0.000562	CcSEcCtD
Lamivudine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000349	0.000561	CcSEcCtD
Lamivudine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000346	0.000554	CcSEcCtD
Lamivudine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000341	0.000547	CcSEcCtD
Lamivudine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00034	0.000545	CcSEcCtD
Lamivudine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000339	0.000544	CcSEcCtD
Lamivudine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000337	0.000541	CcSEcCtD
Lamivudine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000332	0.000533	CcSEcCtD
Lamivudine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000328	0.000526	CcSEcCtD
Lamivudine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000322	0.000517	CcSEcCtD
Lamivudine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000322	0.000517	CcSEcCtD
Lamivudine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000321	0.000515	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00032	0.000513	CcSEcCtD
Lamivudine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000318	0.00051	CcSEcCtD
Lamivudine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000313	0.000502	CcSEcCtD
Lamivudine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000309	0.000495	CcSEcCtD
Lamivudine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000309	0.000495	CcSEcCtD
Lamivudine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000492	CcSEcCtD
Lamivudine—PGK1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000304	0.0018	CbGpPWpGaD
Lamivudine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000304	0.000487	CcSEcCtD
Lamivudine—ABCG2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000303	0.00179	CbGpPWpGaD
Lamivudine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000303	0.000486	CcSEcCtD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000302	0.00179	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000301	0.00178	CbGpPWpGaD
Lamivudine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.0003	0.000481	CcSEcCtD
Lamivudine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000479	CcSEcCtD
Lamivudine—DCK—Metabolism—GC—chronic obstructive pulmonary disease	0.000296	0.00175	CbGpPWpGaD
Lamivudine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000472	CcSEcCtD
Lamivudine—SLC22A1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000293	0.00173	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APIP—chronic obstructive pulmonary disease	0.00029	0.00172	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000286	0.00169	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000286	0.00169	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000286	0.00169	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000283	0.00168	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000282	0.00167	CbGpPWpGaD
Lamivudine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000281	0.000451	CcSEcCtD
Lamivudine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000281	0.000451	CcSEcCtD
Lamivudine—NME2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00028	0.00166	CbGpPWpGaD
Lamivudine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000279	0.000448	CcSEcCtD
Lamivudine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000445	CcSEcCtD
Lamivudine—DCK—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000275	0.00163	CbGpPWpGaD
Lamivudine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000272	0.000436	CcSEcCtD
Lamivudine—NT5C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000271	0.0016	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000271	0.0016	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000271	0.0016	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000271	0.0016	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.000269	0.00159	CbGpPWpGaD
Lamivudine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000268	0.00043	CcSEcCtD
Lamivudine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000268	0.00043	CcSEcCtD
Lamivudine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000268	0.000429	CcSEcCtD
Lamivudine—ABCC3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000266	0.00158	CbGpPWpGaD
Lamivudine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000427	CcSEcCtD
Lamivudine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000266	0.000427	CcSEcCtD
Lamivudine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000423	CcSEcCtD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00026	0.00154	CbGpPWpGaD
Lamivudine—NME2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.00153	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.000256	0.00152	CbGpPWpGaD
Lamivudine—PGK1—Disease—ERBB3—chronic obstructive pulmonary disease	0.000256	0.00151	CbGpPWpGaD
Lamivudine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000408	CcSEcCtD
Lamivudine—PGK1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000253	0.0015	CbGpPWpGaD
Lamivudine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000405	CcSEcCtD
Lamivudine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.000405	CcSEcCtD
Lamivudine—PGK1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00025	0.00148	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.000247	0.00146	CbGpPWpGaD
Lamivudine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000245	0.000393	CcSEcCtD
Lamivudine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000391	CcSEcCtD
Lamivudine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000391	CcSEcCtD
Lamivudine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000243	0.00144	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000236	0.00139	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000236	0.00139	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.000235	0.00139	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000235	0.00139	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000233	0.00138	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000233	0.00138	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000232	0.00137	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000232	0.00137	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000231	0.00136	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.00023	0.00136	CbGpPWpGaD
Lamivudine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000365	CcSEcCtD
Lamivudine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000355	CcSEcCtD
Lamivudine—PGK1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000221	0.00131	CbGpPWpGaD
Lamivudine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00035	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000216	0.00128	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000215	0.00128	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000215	0.00127	CbGpPWpGaD
Lamivudine—PGK1—Disease—NOS2—chronic obstructive pulmonary disease	0.000213	0.00126	CbGpPWpGaD
Lamivudine—NME2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000212	0.00126	CbGpPWpGaD
Lamivudine—NME1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000212	0.00126	CbGpPWpGaD
Lamivudine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000339	CcSEcCtD
Lamivudine—ABCC1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000209	0.00124	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000205	0.00121	CbGpPWpGaD
Lamivudine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000327	CcSEcCtD
Lamivudine—ABCC4—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000204	0.00121	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000198	0.00117	CbGpPWpGaD
Lamivudine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000315	CcSEcCtD
Lamivudine—NME1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000196	0.00116	CbGpPWpGaD
Lamivudine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000312	CcSEcCtD
Lamivudine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000312	CcSEcCtD
Lamivudine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00031	CcSEcCtD
Lamivudine—SLC22A3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000192	0.00114	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00019	0.00112	CbGpPWpGaD
Lamivudine—NME2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00111	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GC—chronic obstructive pulmonary disease	0.000187	0.00111	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000184	0.00109	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ALB—chronic obstructive pulmonary disease	0.000184	0.00109	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000184	0.00109	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000184	0.00109	CbGpPWpGaD
Lamivudine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000294	CcSEcCtD
Lamivudine—ABCC4—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000183	0.00108	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000182	0.00108	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000181	0.00107	CbGpPWpGaD
Lamivudine—PGK1—Disease—SERPINE1—chronic obstructive pulmonary disease	0.00018	0.00106	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000176	0.00104	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000176	0.00104	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000176	0.00104	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000176	0.00104	CbGpPWpGaD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000176	0.00104	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00104	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000174	0.00103	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000173	0.00103	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000173	0.00102	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GC—chronic obstructive pulmonary disease	0.000172	0.00102	CbGpPWpGaD
Lamivudine—PGK1—Disease—NOS3—chronic obstructive pulmonary disease	0.000171	0.00101	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000169	0.001	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000165	0.000975	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000163	0.000966	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000162	0.000961	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000162	0.000956	CbGpPWpGaD
Lamivudine—NME1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000161	0.000953	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00016	0.000945	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00016	0.000944	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000153	0.000903	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—ALB—chronic obstructive pulmonary disease	0.00015	0.000888	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.00015	0.000888	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000149	0.000881	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000149	0.000881	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000146	0.000862	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000144	0.000849	CbGpPWpGaD
Lamivudine—NME1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.000842	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ALB—chronic obstructive pulmonary disease	0.000139	0.000826	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000138	0.000818	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.000812	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000137	0.00081	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	0.000135	0.000796	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.000795	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000133	0.00079	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000133	0.000785	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000132	0.000783	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000129	0.000762	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000129	0.000762	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000128	0.000755	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000127	0.000753	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.000753	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000125	0.00074	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000124	0.000736	CbGpPWpGaD
Lamivudine—NME2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000122	0.000722	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000122	0.00072	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00012	0.000713	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000119	0.000706	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	0.000118	0.0007	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000118	0.000697	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	0.000117	0.000693	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000116	0.000684	CbGpPWpGaD
Lamivudine—PGK1—Disease—TGFB1—chronic obstructive pulmonary disease	0.000113	0.000671	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000112	0.000664	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000112	0.000663	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000112	0.000663	CbGpPWpGaD
Lamivudine—PGK1—Disease—EGFR—chronic obstructive pulmonary disease	0.000111	0.000658	CbGpPWpGaD
Lamivudine—DCK—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00011	0.000654	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.00011	0.000653	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00011	0.000651	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.00011	0.000648	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000109	0.000646	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000109	0.000644	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000109	0.000642	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.000108	0.000638	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000107	0.000635	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000106	0.000629	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000103	0.000609	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000103	0.000609	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000102	0.000604	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000101	0.000601	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000101	0.000597	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.96e-05	0.00059	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	9.93e-05	0.000588	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	9.89e-05	0.000585	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.76e-05	0.000577	CbGpPWpGaD
Lamivudine—NME1—Metabolism—ALB—chronic obstructive pulmonary disease	9.67e-05	0.000572	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.44e-05	0.000558	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.38e-05	0.000555	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.34e-05	0.000553	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GCLC—chronic obstructive pulmonary disease	9.27e-05	0.000549	CbGpPWpGaD
Lamivudine—NME1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.25e-05	0.000547	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	9.23e-05	0.000547	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CTGF—chronic obstructive pulmonary disease	9.2e-05	0.000545	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	8.94e-05	0.000529	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.94e-05	0.000529	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	8.93e-05	0.000528	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.7e-05	0.000515	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.64e-05	0.000512	CbGpPWpGaD
Lamivudine—PGK1—Disease—IL6—chronic obstructive pulmonary disease	8.54e-05	0.000505	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	8.54e-05	0.000505	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.48e-05	0.000502	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CTGF—chronic obstructive pulmonary disease	8.46e-05	0.000501	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.22e-05	0.000486	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.79e-05	0.000461	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.73e-05	0.000457	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	7.37e-05	0.000436	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.35e-05	0.000435	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.26e-05	0.00043	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.07e-05	0.000419	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.97e-05	0.000413	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KL—chronic obstructive pulmonary disease	6.86e-05	0.000406	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.77e-05	0.000401	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.73e-05	0.000398	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ALB—chronic obstructive pulmonary disease	6.63e-05	0.000392	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.63e-05	0.000392	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.58e-05	0.000389	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.52e-05	0.000386	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.5e-05	0.000385	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.5e-05	0.000385	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.47e-05	0.000383	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.44e-05	0.000381	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.41e-05	0.000379	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	6.4e-05	0.000379	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.4e-05	0.000379	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.39e-05	0.000378	CbGpPWpGaD
Lamivudine—DCK—Metabolism—NOS3—chronic obstructive pulmonary disease	6.34e-05	0.000375	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.33e-05	0.000374	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.16e-05	0.000365	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.15e-05	0.000364	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.11e-05	0.000361	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.97e-05	0.000354	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.96e-05	0.000353	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.95e-05	0.000352	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.9e-05	0.000349	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.83e-05	0.000345	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.77e-05	0.000342	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.67e-05	0.000335	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.66e-05	0.000335	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.65e-05	0.000334	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.61e-05	0.000332	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.38e-05	0.000318	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.37e-05	0.000318	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.32e-05	0.000315	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.32e-05	0.000315	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.23e-05	0.000309	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	5.14e-05	0.000304	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.1e-05	0.000302	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.09e-05	0.000301	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.02e-05	0.000297	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.96e-05	0.000293	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.88e-05	0.000289	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.78e-05	0.000283	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.68e-05	0.000277	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	4.65e-05	0.000275	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.56e-05	0.00027	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.48e-05	0.000265	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.44e-05	0.000263	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.44e-05	0.000262	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.42e-05	0.000262	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.37e-05	0.000259	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	4.28e-05	0.000254	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—chronic obstructive pulmonary disease	4.19e-05	0.000248	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.13e-05	0.000245	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.12e-05	0.000244	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.08e-05	0.000241	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.08e-05	0.000241	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.02e-05	0.000238	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NOS3—chronic obstructive pulmonary disease	4.01e-05	0.000237	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.9e-05	0.000231	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.86e-05	0.000229	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	3.85e-05	0.000228	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.8e-05	0.000225	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.68e-05	0.000218	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	3.61e-05	0.000214	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.6e-05	0.000213	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.5e-05	0.000207	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.46e-05	0.000205	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	3.44e-05	0.000204	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.15e-05	0.000187	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.06e-05	0.000181	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	3.02e-05	0.000178	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.91e-05	0.000172	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.88e-05	0.000171	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	2.65e-05	0.000157	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.63e-05	0.000155	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.54e-05	0.00015	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.51e-05	0.000149	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.45e-05	0.000145	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.42e-05	0.000143	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.39e-05	0.000141	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.34e-05	0.000139	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	2.28e-05	0.000135	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	2.23e-05	0.000132	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.23e-05	0.000132	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.11e-05	0.000125	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	1.72e-05	0.000102	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.43e-05	8.49e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.37e-05	8.12e-05	CbGpPWpGaD
